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identify novel inhibitors of EI. We identify three molecular fragments that allosterically inhibit the 
phosphoryl transfer reaction catalyzed by EI by interacting with the enzyme at a surface pocket located 
more than 10 Å away from the substrate binding site. Interestingly, although the three molecules share 
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provides structural foundation for the different inhibitory activity of the identified molecular fragments. In 
particular, we show that contacts between the inhibitor and the side-chain of V292 are crucial to 
destabilize binding of the substrate to EI. In contrast, mixed inhibition is caused by additional contacts 
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A B S T R A C T
Enzyme I (EI), which is the key enzyme to activate the bacterial phosphotransferase system, plays an important
role in the regulation of several metabolic pathways and controls the biology of bacterial cells at multiple levels.
The conservation and ubiquity of EI among different types of bacteria makes the enzyme a potential target for
antimicrobial research. Here, we use NMR-based fragment screening to identify novel inhibitors of EI. We
identify three molecular fragments that allosterically inhibit the phosphoryl transfer reaction catalyzed by EI by
interacting with the enzyme at a surface pocket located more than 10 Å away from the substrate binding site.
Interestingly, although the three molecules share the same binding pocket, we observe that two of the discovered
EI ligands act as competitive inhibitors while the third ligand acts as a mixed inhibitor. Characterization of the
EI-inhibitor complexes by NMR and Molecular Dynamics simulations reveals key interactions that perturb the
fold of the active site and provides structural foundation for the different inhibitory activity of the identified
molecular fragments. In particular, we show that contacts between the inhibitor and the side-chain of V292 are
crucial to destabilize binding of the substrate to EI. In contrast, mixed inhibition is caused by additional contacts
between the inhibitor and ⍺-helix 2 that perturb the active site structure and turnover in an allosteric manner.
We expect our results to provide the basis for the development of second generation allosteric inhibitors of
increased potency and to suggest novel molecular strategies to combat drug-resistant infections.
1. Introduction
The bacterial phosphoenolpyruvate (PEP):carbohydrate phospho-
transferase system (PTS) is a signal transduction pathway that is in-
volved in both transport and phosphorylation of a large number of
carbohydrates (PTS carbohydrates), in the movement of cells toward
these carbon sources (chemotaxis), in biofilm formation, in the reg-
ulation of interactions between carbon and nitrogen metabolisms, and
in the regulation of a number of other metabolic pathways, including
catabolic gene expression, potassium transport, and inducer exclusion
(Deutscher et al., 2014; Postma et al., 1996). For all these different
regulatory processes, the signal is provided by the phosphorylation
state of the PTS components (Deutscher et al., 2014), which varies
according to the intracellular availability of PEP (Hogema et al., 1998).
PEP acts as phosphoryl donor for Enzyme I (EI), which, together with
the phosphocarrier protein HPr and one of sugar-specific EIIA and EIIB
pairs, forms a phosphorylation cascade that allows phosphorylation of
the PTS carbohydrate bound to the membrane-spanning EIIC (Clore and
Venditti, 2013). PTS-mediated regulatory mechanisms are based either
on direct phosphorylation of the target protein by one of the PTS
components or on phosphorylation-dependent interactions (Deutscher
et al., 2014). As such, the regulatory functions of PTS are strongly
impaired by inhibition of EI phosphorylation by PEP. Indeed, an Es-
cherichia coli strain engineered to not express EI only grows in complex
media containing cyclic adenosine monophosphate (which is needed to
activate catabolic gene expression in EI-deficient strains) (Postma et al.,
1996), and the growth of wild-type E. coli, Pseudomonas aeruginosa, and
Staphylococcus aureus on Luria-Bertani (LB) or Tryptic Soy broth is se-
verely affected by addition of EI inhibitors designed in silico (Huang
et al., 2013). Moreover, a virulence study in a murine model has shown
that EI-deficient strains of Salmonella typhimurium, S. aureus, and Hae-
mophilus influenzae are 10 to 1000 times less virulent than wild type
bacteria (Kok et al., 2003), and PTS genes have been identified on
several occasions in experimental screens for virulence factors
(Edelstein et al., 1999; Hava and Camilli, 2002; Jones et al., 2000; Lau
et al., 2001). Therefore, potent inhibitors of EI could show anti-
microbial activity by attenuating both growth rate and virulence of the
infective agent. Interestingly, EI is ubiquitous and one of the best-
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conserved proteins in both Gram-positive and Gram-negative bacteria,
and does not share any significant sequence similarity with eukaryotic
proteins, making EI a possible target for development of wide-spectrum
antimicrobials.
The functional form of EI is a 128 kDa symmetric dimer of identical
subunits. Each subunit is composed of two structurally and functionally
distinct domains separated by a long helical linker (Chauvin et al.,
1996). The N-terminal domain (EIN, residues 1–249) contains the
phosphorylation site (H189) and the binding site for HPr (the second
PTS protein). The C-terminal domain (EIC, residues 261–575) is re-
sponsible for EI dimerization and contains the binding site for PEP.
Functional regulation of EI is achieved through synergistic coupling of
multiple intra and interdomain conformational equilibria that are
modulated by substrate and cofactor binding. Specifically, EI undergoes
(i) a monomer–dimer equilibrium (Nguyen et al., 2018; Patel et al.,
2006), (ii) a compact-to-expanded equilibrium within the EIC domain
(Venditti and Clore, 2012; Venditti et al., 2015b), (iii) a g+-to-g−
equilibrium within the rotameric state of the H189 side chain (Suh
et al., 2008), (iv) a state A-to-state B equilibrium within the EIN domain
(Schwieters et al., 2010; Teplyakov et al., 2006), and (v) an open-to-
close equilibrium describing a reorientation of EIN relative to EIC
(Schwieters et al., 2010; Teplyakov et al., 2006; Venditti et al., 2015a;
Venditti et al., 2015b). PEP binding to EIC stabilizes the dimer/com-
pact/g−/state B/closed form of EI and activates the enzyme for cata-
lysis (Nguyen et al., 2018; Venditti et al., 2015b). Therefore, in addition
to its pharmacological relevance, EI is also an important model system
for biophysical investigations on long-range allosteric communication
in multi-domain, oligomeric proteins.
Here, we use NMR-based fragment screening to identify novel
strategies for selective inhibition of E. coli EI. Starting from a library of
1000 molecular fragments, we identify three novel inhibitors of the
enzyme (Fig. 1) that bind the EIC domain at a surface pocket separated
more than 10 Å from the active site. Interestingly, although the three
allosteric inhibitors share the same binding pocket, investigation of the
reaction kinetics indicates that they inhibit the enzyme using different
mechanisms. Computational studies reveal that the intrinsic flexibility
of the inhibitors is chiefly responsible for their different mechanism of
action, and provide hints as to how to evolve second generation
inhibitors of increased potency. Such molecules will provide novel
molecular tools to interrogate allosteric communication in EI and could
potentially function as a new class of wide-spectrum antimicrobials.
2. Results and discussion
2.1. Identification of small-molecule ligands of EI
Novel small-molecule ligands of EI were identified by screening a
rule-of-three-compliant library of 1000 molecular fragments against EI
by Saturation Transfer Difference (STD) and Chemical Shift
Perturbation (CSP) NMR experiments (Carr et al., 2005). In STD NMR,
the target protein is mixed with one (or more) small molecule(s) and
the transfer of saturation from the protein to the small molecule is in-
vestigated by solution NMR (Mayer and Meyer, 2001). Ligand protons
that are in close contact with the receptor protein receive a higher
degree of saturation and generate stronger STD NMR signals. In con-
trast, protons that are not in contact with the target protein reveal no
STD NMR signals. Therefore, STD NMR is an excellent tool to rapidly
screen a small library of potential ligands against EI, as only ligands of
the enzyme will return an STD NMR signal (Fig. 2a). To reduce the
experimental time for STD screening, fragments were screened in pools
of five, corresponding to a total of 200 NMR samples. Pools were ranked
by their signal intensities, which were calculated as the sum of the
intensity of the STD spectrum over the entire spectral width (Fig. 2b).
The 25 pools returning the strongest STD signals were counterscreened
against the enzyme by CSP experiments. These protein-detected NMR
experiments are orthogonal to the ligand-detected STD experiments,
and provide an independent validation for the ligand–protein interac-
tions revealed by STD screening (Ma et al., 2016). CSP-based screening
consists in measuring 1H-15N heteronuclear single quantum coherence
(HSQC) spectra of the target protein in the absence and in the presence
of the molecular fragment pool. Pools containing one (or more) ligand
(s) of the receptor protein generate shifts of the NMR signals that are
easily observable by overlaying the measured HSQC spectra (Fig. 2c)
(Purslow et al., 2020). To facilitate acquisition and analysis of the NMR
data, CSP experiments were measured on 15N-labeled samples of the
isolated N- (EIN) and C-terminal (EIC) domains of EI that, being con-
siderably smaller than the full-length protein, generate highly resolved
NMR spectra characterized by high signal-to-noise ratio. In total, 30 EI
ligands were identified from 20 fragment pools selected by our com-
bined STD/CSP screening. The EI ligands were recognized from the
other molecules comprising the fragment pools by comparing the pat-
tern of the STD-NMR signals with reference 1H NMR spectra provided
by the commercial supplier of the fragment library.
The affinity of the newly discovered EI ligands was investigated by
acquiring CSP-based, NMR titration experiments on 15N-labeled EIN or
EIC at increasing concentration of small molecule (Fielding, 2007). The
data were fit using a standard equilibrium dissociation equation
(Granot, 1983) to obtain the equilibrium dissociation constant (KD) per
each analyzed complex (Fig. 2d). This analysis identified six small
molecules that bind the EIC domain of EI with low mM affinity
(Fig. 2e).
2.2. Identification of small-molecule inhibitors of EI
The six small-molecule ligands of EI identified above (compounds
1–6 in Fig. 2e) were characterized for their ability to inhibit the
phosphoryl-transfer reaction from PEP to HPr catalyzed by the enzyme.
The activity of full-length EI was assayed in the presence of 0.0, 1.5, and
6.0 mM of compounds 1–6 by 1H-15N SOFAST NMR experiments
(Nguyen et al., 2018). This method was employed recently to study the
effect of protein oligomerization on EI functional response to α-ke-
toglutarate binding, and allows to assay the activity of EI without in-
terferences due to the PEP-hydrolysis reaction catalyzed by the EIC
domain (Nguyen et al., 2018). Results of the enzymatic assay are
Fig. 1. Fragment screening pipeline. Scheme of the experimental protocol
employed for discovery of novel inhibitors of EI. A library of 1,000 molecular
fragments is screened against EI by STD and CSP NMR experiments. The affinity
of 30 positive hits for the enzyme is characterized by NMR titration experi-
ments. 6 low-millimolar ligands are tested for their ability to inhibit the
phosphoryl-transfer reaction catalyzed by the enzyme, resulting in discovery of
3 allosteric inhibitors of EI.
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reported in Fig. 3b as Lineweaver–Burk plots. In such graphs, the y and
x intercepts are equivalent to the inverse of the maximum velocity (1/
Vmax) and the negative inverse of the Michaelis constant (−1/Km), re-
spectively. We observed that only compounds 1–3 are inhibitors of EI.
In particular, compounds 1 and 2 act as competitive inhibitors (i.e. their
presence increases the Km for PEP binding to EI, Fig. 3b), while
compound 3 acts as mixed inhibitor of EI (i.e. its presence increases Km
and decreases Vmax for the enzymatic reaction, Fig. 3b).
The enzyme kinetic data were modelled using a competitive in-
hibition model (Eq. (3)) for compounds 1 and 2, and a mixed inhibition
model (Eq. (4)) for compound 3. Modelling was performed by keeping
Km,0 (the value of Km in the absence of inhibitor) to its literature value
Fig. 2. STD/CSP screening against EI. (a) Example STD-
NMR spectra of a positive (top) and a negative (bottom)
hit of the fragment screening. (b) The intensity of the STD
spectra is plotted versus the pool index. Pools are ordered
for decreasing intensity of the STD spectrum. The vertical
dashed line indicates the best 25 pools that were coun-
terscreened by CSP. STD signal intensities are normalized
relative to the most intense STD spectrum. (c) 1H-15N
HSQC spectra of 15N-labeled EIC acquired in the absence
(red) and in the presence (blues) of a pool of molecular
fragments. Example of a negative (left) and a positive
(red) hit are provided. (d) Binding isotherms obtained for
the best six ligands of EI by NMR titration experiments
(compounds 1–6). Experimental data are shown as cir-
cles. Modelling of the data is shown as solid lines. Color
code is red, orange, green, yellow, blue, and light blue for
compound 1, 2, 3, 4, 5, and 6, respectively. (e) Line
structures of compounds 1–6. KD values fitted from the
binding isotherms are shown. (For interpretation of the
references to color in this figure legend, the reader is
referred to the web version of this article.)
 
Fig. 3. Enzyme inhibition assays. (a) Example
plots showing the initial change in the concentra-
tion of unphosphorylated HPr versus time in the
presence of 500 μM PEP and 0.1 μM EI. (b) Enzyme
kinetic data shown as Lineweaver-Burk plots. (c)
Enzyme kinetic data shown as Michaelis-Menten
plots. The enzyme inhibition assays were run in the
presence of compound 1 (top), 2 (center), and 3
(bottom). Data were measured at three different
concentrations of inhibitor (0.0 mM, red; 1.5 mM,
blues; 6.0 mM, green). Michaelis-Menten plots
were modelled using a competitive (solid line) or
mixed (dashed line) inhibition model (see Eqs. (3)
and (4)). Lineweaver-Burk plots were interpolated
by linear regression, and the vertical dotted lines
indicate the position of the y-axis. Experimental
data are shown as circles. (For interpretation of the
references to color in this figure legend, the reader
is referred to the web version of this article.)
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(350 μM) and the KI’s for compounds 1–3 to the corresponding KD’s
measured by NMR titration experiments (2.5, 2.6, and 3.2 mM for
compound 1, 2, and 3, respectively - Fig. 2e). Vmax,0 (the value of Vmax
in the absence of inhibitor) was optimized to maximize the agreement
between experimental and simulated data (Fig. 3c). A best fit Vmax,0
value of 19 ± 2 μM min−1 was obtained.
2.3. Structural basis for inhibition of EI
To gain structural insight into the interaction between EI and
compounds 1–3, the combined 1HN/15N CSP (ΔH/N) generated by 8 mM
inhibitor on the 1H-15N HSQC spectrum of isolated EIC are plotted on
the enzyme structure in Fig. 4. NMR chemical shifts depend on the local
electronic environment at the observed nuclei. Therefore, CSP data
report on local changes of the electronic structure due to the presence of
the ligand or to protein conformational changes occurring upon ligand
binding. Fig. 4 displays that compounds 1–3 generate large ΔH/N values
at a small pocket formed by the C-terminal ends of ⍺-helix 1 (residues
268–278) and 2 (residues 310–325) of the EIC domain, suggesting that
the three molecules share the same binding site. Interestingly, this
surface pocket is located greater than 10 Å away from the binding site
for PEP (Fig. 4), indicating that compounds 1–3 perturb the affinity of
the EI-PEP complex (Fig. 3) in an allosteric manner. Of note, compound
3 generates additional CSP at the N-terminal end of the EIC domain and
at the β3α3 loop of the active site (Fig. 4). This observation suggests
that compound 3 induces conformational changes at the active site of EI
that might be responsible for the ability of compound 3 to reduce the
Vmax for the phosphoryl-transfer reaction (Fig. 3). Alternatively, the
additional CSP induced by compound 3 might indicate the existence of
a second binding site on EIC. However, we tend to exclude this hy-
pothesis for two reasons: (i) fitting CSP titration data for the residues in
the allosteric binding pocket and for the residues in the β3α3 loop se-
parately returns KD values that are identical within experimental error
(3.2 ± 0.2 mM and 3.5 ± 0.3 mM, respectively), and (ii) MD
Fig. 4. Structures of the EIC-inhibitor complexes. (a) Weighted combined chemical shift perturbations (ΔH/N) induced by 8 mM of compound 1 (top), 2 (center) and 3
(bottom) on the 1H-15N HSQC spectrum of EIC. ΔH/N values are displayed on the structure of the EIC-PEP complex as spheres with the relationship between size and
color of each sphere and chemical shift perturbation depicted by the color bar. The PEP molecule is shown as solid sticks. Structure and localization of compounds 1,
2, and 3 resulting from molecular docking calculation is also displayed as solid sticks. (b) Close-up view of the inhibitor binding site. Inhibitors and EIC side-chains
involved in complex formation are shown as solid sticks. (c) 2D ligand–protein interaction diagrams of the EIC-inhibitor complexes highlighting hydrophobic
contacts (red) and hydrogen-bonding (dashed green line) interactions. Plots were generated using the program LigPlot (Wallace et al., 1995). (For interpretation of
the references to color in this figure legend, the reader is referred to the web version of this article.)
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simulations data indicate that binding of compound 3 to the pocket at
the C-terminal ends of ⍺-helices 1 and 2 perturbs the structure of the
β3α3 loop (see below).
Atomic-resolution structural models for the complexes formed by
EIC with compounds 1–3 were constructed by molecular docking of one
copy of the ligand into the binding pocket defined by CSP data (i.e. the
surface pocket defined by the C-terminal ends of ⍺-helix 1 and 2,
Fig. 4a). Calculations were run with AutoDock as described in Methods,
and the resulting structures are displayed in Fig. 4. As expected from
the close similarity of the chemical structures of the three ligands
(Fig. 2e), compounds 1–3 adopt a similar binding mode on EIC. Indeed,
for all ligands, the hydrophobic aromatic ring dives into the hydro-
phobic pocket formed by ⍺-helices 1 and 2, while hydrophilic groups
remain solvent exposed. Of note, all small molecules make close con-
tacts with the side chain of V292 (Fig. 4), which is located at the N-
terminal end of β-strand 2 (residues 292–296). As β-strand 2 is re-
sponsible for two key interactions that stabilize binding of PEP to EIC
(namely: an hydrophobic contact between the L294 side-chain and the
CH2 group of PEP, and a salt-bridge between the side chain of R296 and
the phosphate group of PEP) (Venditti and Clore, 2012; Venditti et al.,
2013), these contacts between the inhibitors and V292 can perturb the
structure and or the dynamics of the PEP binding site and be re-
sponsible for the effects of compounds 1–3 on the KM of the EIC-PEP
complex. Significant differences in the way compounds 1–3 bind the
enzyme are observed at the level of ⍺-helix 2. Indeed, while compounds
1 and 2 make minimal contacts with the C-terminal end of ⍺-helix 2, the
presence of the sp3 C bridging the two aromatic groups of compound 3
allows this inhibitor to bend and form extensive contacts with S326 and
Q327 (Fig. 4). As this helix is directly connected to the protein active
site via the β2α2 loop (which directly contacts the active site β3α3
loop), we hypothesize that the interactions established by compound 3
with S326 and Q327 perturb the structure of the active-site and are,
therefore, responsible for the effect of this inhibitor on Vmax.
The structural basis for the mixed inhibition of EI caused by com-
pound 3 has been investigated further by means of Molecular Dynamics
(MD) simulations. In particular, 400-ns long MD simulations were run
by using the docking EIC-inhibitor complexes as the starting structures.
EIC was simulated in its physiological, dimeric form (Nguyen et al.,
2018; Patel et al., 2006; Venditti and Clore, 2012) with inhibitors
bound to both subunits. Stability of the simulations was evaluated by
plotting the heavy-atom root mean square deviation (r.m.s.d.) from the
starting structure versus time (Fig. 5a). Analysis of these plots high-
lights the greater rigidity of compound 2 compared to compounds 1 and
3, which show recurrent transitions to alternative rotameric structures
(note the sharp transitions in r.m.s.d. versus time observed for com-
pounds 1 and 3 in the MD simulations). Despite this intrinsic flexibility,
the hydrophilic ring of compound 3 contacts the C-terminal end of
⍺-helix 2 for the entire 400-ns trajectory, as evidenced by the fact that
the hydrogen-bond between the hydroxyl group of S296 and the amine
group of the inhibitor persists for the majority of the MD simulation
(Fig. 5b).
To analyze if EIC undergoes different dynamics when bound to the
three small molecule inhibitors, we performed a ‘combined’ principal
component analysis (PCA) on the simulated trajectories (van Aalten
et al., 1995). In this method, two or more trajectories (fitted on the
same reference structure) are concatenated, and a covariance matrix is
constructed and diagonalized to obtain a common set of eigenvectors,
describing the variance of the atomic coordinates in the combined MD
simulation, and eigenvalues, describing the extent of the atomic fluc-
tuations in the corresponding eigenvectors. When PCA is performed on
a concatenated trajectory and eigenvectors are ordered by decreasing
eigenvalue, significant differences in the structure and dynamics of the
simulated systems (in our case the three EIC-inhibitor complexes) are
described by the first few eigenvectors (van Aalten et al., 1995). In the
particular case of EIC, we have created three 800-ns trajectories (one
per each EIC-inhibitor complex) by appending the 400-ns trajectory of
the second subunit to the 400-ns trajectory of the first subunit of the EIC
dimer. These three 800-ns trajectories were concatenated together and
investigated by combined PCA performed on the coordinates of Cα
atoms of EIC. Once a common set of PC’s are obtained, the separate
800-ns trajectories are projected onto the resulting eigenvectors, and
the properties of these projections are compared for all simulations. In
particular, there are two main quantities of interest: the average pro-
jection and the root mean square fluctuation (r.m.s.f.) in the projection.
Differences in the average projection on a particular eigenvector in-
dicate that the simulations have different average displacement (i.e.
average structure) in that PC. In contrast, r.m.s.f. differences in a par-
ticular eigenvector indicate that the simulations have different dy-
namics in the collective motion described by that PC. Analysis of the
first 10 PC’s indicates that the simulated EIC-inhibitor complexes have
similar molecular dynamics (i.e. similar r.m.s.f. versus eigenvector
plots) but different equilibrium structures (Fig. 6a). In particular,
structural changes are described by the first four PC’s, in which EIC
bound to compound 3 has average projections considerably different
from the ones of EIC bound to compounds 1 and 2 (Fig. 6a). The col-
lective motions described by the first four PC’s are displayed in Fig. 6b
by superimposing the start and the end frames of the pseudo-trajectory
describing each eigenvector. A pseudo-trajectory with a negative
average displacement has an equilibrium structure shifted toward the
start point of the concerted motion, while a positive average displace-
ment indicates that the average structure of the pseudo-trajectory is
shifted toward the end point of the concerted motion. Inspection of
Fig. 6 reveals that the first four PC’s describe collective motions
Fig. 5. MD simulations of the EIC-inhibitor complexes. (a) Heavy-atom r.m.s.d.
to the docking structure versus time calculated for the 400-ns MD run on the
EIC-inhibitor complexes. EIC was simulated in its physiological dimeric form
with inhibitors bound to both subunits. The r.m.s.d. calculated for the EIC, the
inhibitor bound to the first subunit, and the inhibitor bound to the second
subunit are colored black, light blue, and orange, respectively. Top, center, and
bottom plots are for the complexes with compound 1, 2, and 3, respectively. (b)
The distance between the hydroxyl group of S326 and the amine group of
compound 3 is plotted versus time. Data for subunit 1 and 2 are colored light
blue and orange, respectively. The dotted line is at 2.4 Å to indicate the distance
required for hydrogen-bond formation. (For interpretation of the references to
color in this figure legend, the reader is referred to the web version of this
article.)
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involving the C-terminal helix and the active site β2α2, β3α3, and β6α6
loops of EIC. In particular, the active site β3α3 loop undergoes a closed-
to-open (start-to-end) conformational equilibrium on PC’s 1 and 4, with
compounds 1 and 2 favoring the closed conformation (note that the
average projections of the simulations with compounds 1 and 2 on PC’s
1–4 are negative) and compound 3 favoring the open conformation
(note that the average projections of the simulation with molecule 3 on
PC’s 1–4 are positive). As the β3α3 loop of EIC has to adopt a fully
closed configuration for efficient EI catalysis (Dotas et al., 2020), we
ascribe the mixed inhibitor behavior of compound 3 to its ability to
destabilize the catalytically-competent, fully closed conformation of the
β3α3 loop.
3. Conclusion
EI is emerging as an important model system to study allosteric
regulation in multidomain, oligomeric enzymes, and as a promising
pharmaceutical target for antimicrobial design. In this contribution, we
have characterized a novel surface pocket localized on the EIC domain
that is allosterically coupled to the enzyme active site. By using NMR-
based fragment screening, we identify three small molecules (referred
to as compounds 1, 2, and 3) that bind to the allosteric pocket and
inhibit the phosphoryl-transfer activity of EI. Interestingly, the KD va-
lues measured for the three EIC-inhibitor complexes (~3 mM) are
comparable to the equilibrium dissociation constant reported for the
EIC interaction with α-ketoglutarate (~2 mM) (Venditti et al., 2013), a
metabolite that acts simultaneously as a competitive inhibitor and an
allosteric stimulator of the enzyme (Nguyen et al., 2018), and that was
shown to regulate the activity of EI in vivo (Doucette et al., 2011;
Nguyen et al., 2018). Therefore, the inhibitors identified here can be
used as chemical probes to investigate long-range communication in EI.
On the other hand, testing the druggability of the allosteric pocket
identified here for antimicrobial applications will require evolution of
compounds 1–3 into second generation inhibitors of increased potency.
In this respect, several hints for the development of second generation
allosteric inhibitors can be inferred from the computational studies on
the EIC-inhibitor complexes summarized in Results and discussion.
Importantly, the presence within the inhibitor of a hydrophobic, six-
membered aromatic ring and a more hydrophilic moiety seems crucial
for orienting the molecule inside the aromatic pocket. In particular, it is
imperative that the inhibitor penetrates deep enough into the pocket to
form contacts with V292, which allosterically alter the properties of the
PEP binding site and reduce the affinity of EI for its substrate. In ad-
dition, we notice that formation of contacts between the inhibitor and
the C-terminal end of ⍺-helix 2 allosterically perturbs the structure of
the active site at the β3⍺3 loop. As the β3⍺3 loop is directly involved in
stabilization of the catalytic transition state (Dotas et al., 2020), this
structural rearrangement negatively affects the efficiency of the enzyme
by reducing its turnover number. Our docking and MD results suggest
that introducing a flexible element between the hydrophobic and hy-
drophilic moieties of the inhibitor (such as, for example, the sp3 C in
compound 3) favors formation of extensive contacts with ⍺-helix 2 by
allowing the small molecule to adopt a bent conformation. In alter-
native, branched molecules could be designed starting from compounds
1 and 2 to increase their interactions with the C-terminal end of ⍺-helix
2 and confer mixed inhibitor character to these second generation
compounds. Finally, in silico screening campaigns targeting the allos-
teric site at the C-terminal end of ⍺-helixes 1 and 2 of EIC might provide
additional clues toward evolution of compounds 1–3 and/or suggest
novel lead compounds for inhibition of EI. As the allosteric pocket
Fig. 6. Combined PCA analysis of the MD trajectories. (a) Average projection
(left) and root mean square fluctuations (r.m.s.f.) relative to the average
structure (right) obtained by projecting the MD trajectories of EIC bound to
compound 1 (blue), 2 (green), and 3 (red) on a common set of eigenvectors
obtained from the concatenated trajectory (see main text). Combined PCA
analysis was performed using the coordinates of the C⍺ atoms of EIC. Results
for the first 10 eigenvectors are shown. (b) Start (blue) and end (red) points of
the pseudo-trajectories describing eigenvectors 1–4. Residue-specific r.m.s.f.
values (relative to the average structure) in the eigenvector calculated over
the concatenated trajectory are plotted as color gradient on the start and end
structures to emphasize the specific contribution of different EIC regions to
each eigenvector. (For interpretation of the references to color in this figure
legend, the reader is referred to the web version of this article.)
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identified here is conserved across EI from several bacterial strains
(including important drug-resistant organisms) (Fig. 7), the results and
strategies presented in this work may inspire new, much needed, mo-
lecular routes to inhibition of bacterial infections. However, as the al-
losteric pocket is not fully conserved in all bacterial species, further
investigations are required to investigate the effect of single-point
mutations within the allosteric pocket on the activity and inhibition of
EI. These studies will inform on the ability of the allosteric inhibitors
developed here to inhibit EI from different bacterial strains and to
withstand drug resistance mechanisms.
4. Methods
4.1. Protein expression and purification
E. coli EI and uniformly 15N-labelled EIC, EIN, and HPr were ex-
pressed and purified as previously described (Nguyen et al., 2018; Suh
et al., 2008; Venditti and Clore, 2012).
4.2. Fragment preparation
A commercial library of 1000 molecular fragments was purchased
from ChemBridge. The library was designed to meet the “rule of three”
for fragment-based screening (i.e., molecular weight less than 300 Da,
number of hydrogen bond donors and acceptors does not exceed 3, and
cLogP value less than 3) (Jhoti et al., 2013). To speed up the screening
procedure, the 1000 fragments were pooled in groups of 5. The com-
position of each pool was optimized to reduce the risk of overlap among
the 1H NMR signals of the molecular fragments. Stock solutions were
prepared by dissolving each pool in DMSO‑d6 so that each fragment is
at final concentration of 2.5 mM.
4.3. NMR spectroscopy
All spectra were acquired on Bruker 800 MHz spectrometers
equipped with a z-shielded gradient triple resonance cryoprobe. 1H-15N
HSQC spectra of free EIN, EIC, and HPr were assigned according to
previously reported NMR chemical shifts (Garrett et al., 1999; Venditti
and Clore, 2012; Venditti et al., 2011). NMR samples for STD screening
were prepared in 20 mM phosphate buffer (pD 7.8), 100 mM NaCl,
4 mM MgCl2, and 99.9% D2O. The protein concentration was 10 µM. A
total of 200 NMR samples were prepared by adding 40 µL of fragment
pool stock solution (prepared as described above) directly into the
500 µL (final volume) NMR sample (note that the final concentration of
each fragment in the NMR sample was 200 µM). The 1H STD spectra
were measured at 37 °C by applying a selective saturation field for
400 ms at 20 and 0.9 ppm for the off-resonance and the on-resonance
experiment, respectively. Acquisition was automated by using an au-
tosampler. Spectra were processed and analyzed by using MestReNova
14 (https://mestrelab.com/software/mnova/).
CSP screening experiments were run at 37 °C in 20 mM Tris (pH
7.4), 100 mM NaCl, 4 mM MgCl2, 2 mM DTT, and 5% D2O. The protein
concentration was 400 µM. A total of 40 µL of fragment pool stock
solution were added to the 500 µL NMR sample.
NMR titration experiments were measured at 37 °C in 20 mM Tris
(pH 7.4), 100 mM NaCl, 4 mM MgCl2, 2 mM DTT, and 5% D2O. The
protein concentration was 400 µM and the concentration of small mo-
lecule was varied between 0 and 8 mM. Spectra were processed using
NMRPipe (Delaglio et al., 1995) and analyzed using the program
SPARKY (http://www.cgl.ucsf.edu/home/sparky). Assignment of the
1H-15N cross-peaks for the EIC-small molecule complexes was per-
formed by titration experiments, following the change in 1H-15N cross-
peak positions as a function of added small molecule. Weighted com-
bined 1H/15N chemical shift perturbations (ΔH/N) resulting from the
addition of increasing concentrations of small molecule were calculated
using the following equation (Mulder et al., 1999):
= +δ W δ WΔ (Δ ) (Δ )H N H H N N/ 2 2 (1)
where WH (=1) and WN (=0.154) are weighting factor for the 1H and
15N amide shifts, respectively. ΔδH and ΔδN are the 1H and 15N chemical
shift differences in ppm, respectively, between free and bound states.
The equilibrium dissociation constants (KD) for the EIC-inhibitor com-
plexes were obtained by fitting the changes in ΔH/N with increasing
concentration of small molecule using the equation (Granot, 1983):
=









where Δ0 is the weighted combined 1H/15N chemical shift at saturation,
and P and L are the protein and small molecule concentrations, re-
spectively.
Fig. 7. EI sequence alignment. The sequence of the E. coli EI is aligned against EI from other, randomly selected, drug-resistant bacteria: Citrobacter freundii (identity
97%; similarity 99%; gaps 0%), Klebsiella pneumoniae (identity 96%; Similarity 98%; gaps 0%), Staphylococcus aureus (identity 51%; similarity 70%; gaps 0%),
Enterococcus faecalis (identity 49%; similarity 68%; gaps 1%), and Neisseria gonorrhorae (identity 36%; similarity 58%; gaps 2%). Residues forming the allosteric
pocket are in red. Blue and red lines indicate the EIN and EIC domains, respectively. Dashed lines indicate the locations of ⍺-helices 1 and 2 and β-strand 1. Full
sequence alignments are shown in Supplementary Fig. S1. (For interpretation of the references to color in this figure legend, the reader is referred to the web version
of this article.)
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4.4. Enzymatic assay
Enzyme kinetic assay we run by measuring the rate of phosphoryl
transfer from PEP to HPr catalyzed by full-length EI by using 1H-15N
SOFAST NMR spectra as described previously (Nguyen et al., 2018).
Reaction were run at 25 °C in 20 mM Tris (pH 7.4), 100 mM NaCl, 4 mM
MgCl2, 2 mM DTT, and 5% D2O. The assay was performed in triplicate.
The enzyme kinetic data measured at different concentration of in-



































[ ] [ ]
I S I I, , (4)
where v0 is the initial velocity of the enzymatic reaction, [PEP] and [I]
are the concentration of substrate and inhibitor, respectively, KI,s is the
equilibrium dissociation constant for the enzyme-inhibitor complex, KI,I
is the dissociation constant for the interaction between the inhibitor
and the enzyme-PEP complex, and Km,0 and Vmax,0 are the Michaelis
constant and maximum velocity in the absence of inhibitors, respec-
tively. The seven measured datasets (in the absence of inhibitor, and in
the presence of two concentrations of each inhibitor) were fit globally.
In the global fitting procedures Km,0 was kept fixed to its experimental
value (350 μM), KI,I and KI,S were kept fixed to the value of KD mea-
sured for the EI complexes with compounds 1–3 by NMR CSP experi-
ments, and Vmax,0 was optimized to maximize the agreement between
experimental and simulated data.
4.5. Molecular docking simulations
Molecular docking simulations were run using the coordinates of
the EIC domain from the crystallographic structure of the full-length E.
coli EI (PDB: 2HWG) as the target. Before the actual docking run, the
protein structure was energy minimized by 1000 steps of steep des-
cended followed by 1000 steps of conjugated gradient algorithm.
Energy minimization was performed using the Amber 16 simulation
package (Case et al., 2005) and the Amber ff14SB force field (Maier
et al., 2015). The structures of compounds 1–3 were docked into the
protein using AutoDockTools 1.5.4 and Autodock 4.2 (Morris et al.,
2009). A cubic grid box (grid spacing = 0.373 Å; 40 × 40 × 40 grid
points) was placed at the C-terminal ends of ⍺-helix 1 and 2 of EIC.
Docking was performed using the Lamarckian genetic algorithm (LGA)
and allowing the side chains of E285 and N327 conformational flex-
ibility during the simulations. For the small molecules, the 5 and 6-
membered aromatic rings were considered rigid, while all other bonds
were treated as rotatable. Most of docking parameters were kept as
default, with the exception of the population size (set to 150 with
2,500,000 evaluations) and the maximum number of generations (set to
27,000). Cluster analysis was performed with a r.m.s.d. tolerance of
2 Å. The best conformation is considered to be the conformation with
the lowest free energy of binding.
4.6. Molecular dynamics simulations
The structures of the EIC-inhibitor complexes obtained by molecular
docking simulations were used as the starting point for 400 ns MD si-
mulations ran using the Amber 16 package (Case et al., 2005) and the
Amber ff14SB force field (Maier et al., 2015). EIC was simulated in its
dimer form with inhibitors bound to both subunits. The small molecules
were parameterized with the AM1-BCC charge model (Jakalian et al.,
2002) and the GAFF force field (Huang and Roux, 2013). The initial
complex was centered in a truncated octahedron, filled with TIP3P
water model (Mark and Nilsson, 2001) and neutralizing ions, and the
distance between the protein atoms and the boundaries was set to 10 Å.
Energy minimization of the initial structures, including 1000 steps of
steepest descent and 1000 steps of conjugate gradient, was performed
in 3 stages. First, ions and water positions were relaxed. Then, the EIC-
inhibitor complex was allowed to relax. Finally, the full system was
energy minimized. The system was equilibrated with a 1 ns run in
which the temperature was gradually raised from 0 to 310 K, followed
by a 5 ns run in which the temperature was held constant at 310 K. The
equilibrated system was simulated for 400 ns by keeping the tem-
perature (310 K) and pressure (1 atm) constant. Periodic boundary
conditions were applied, and bonds were restrained with the SHAKE
algorithm (Ryckaert et al., 1977). An integration step of 2 fs was used.
Weak coupling to an external pressure and temperature bath was used
(Berendsen et al., 1984). Particle-Mesh Ewald summation with a cutoff
of 10 Å for long-range interactions was used to treat electrostatic in-
teractions (Essmann et al., 1995).
Analysis of the MD trajectories was performed in Amber 16 using
the CPPTRAJ tool (Roe and Cheatham, 2013). CPPTRAJ was also em-
ployed for combined PCA analysis (van Aalten et al., 1995). Analysis
was performed on the Cα atoms using the protocol described at https://
amberhub.chpc.utah.edu/introduction-to-principal-component-
analysis/.
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